跳至主要内容
临床试验/NCT01892878
NCT01892878撤回不适用

A Prospective, Single Arm Clinical Trial Evaluating Clinical Outcome and Fusion Results Using the VerteLoc® Facet Fixation Device

VG Innovations, LLC2 个研究点 分布在 1 个国家开始时间: 2013年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
2
主要终点
Fusion grade at 12 month follow-up using CT scans

研究概览

简要总结

The purpose of this clinical study is to evaluate fusion of the facet joints in a prospective cohort of patients utilizing the VerteLoc facet fixation device in patients receiving lumbar laminectomy (L1-S1), without ancillary stabilization devices such as pedicle and transfacet screws.

详细描述

Study Design: Non-randomized, prospective, single arm clinical trial

Patient Population and Sample Size: Patients (n=25) from up to 2 clinical site, who have been medically evaluated, found appropriate for, and have agreed to treatment by lumbar decompressive laminectomy and facet fixation, including unilateral and/or bilateral posterolateral fusion according to accepted medical standards.

Objectives:

The primary objective of this study is to:

  1. Evaluate the fusion status of facet joints following laminectomy and facet fixation using the VerteLoc system in combination with unilateral and/or bilateral posterolateral fusion.
  2. Subject success / Clinical outcome: Evaluate the reduction in baseline VAS back pain score at 2-3 weeks, 3 months, and 12 months.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Have provided consent for research by signing the Institutional Review Board approved Informed Consent;
  • Have given appropriate operative consent for a decompressive lumbar (L1-S1) laminectomy procedure as standard of care;
  • Are skeletally mature, and are at least 18 years of age;
  • If female, are not pregnant;
  • Agree to adhere to post-surgical medically prescribed activity limitations and/or physical rehabilitation.

排除标准

  • Previous surgery at the target or adjacent vertebral levels;
  • More than two intervertebral levels to be treated by the laminectomy procedure;
  • Found to be inappropriate candidates for facet fixation using the VerteLoc system;
  • Require additional and/or other surgical technique and/or approach to the laminectomy at the index level(s), which may in the opinion of the Primary Investigator confound measurement of outcome variables;
  • Has a medical disorder or is receiving medications that would be expected to interfere with osteogeneses,
  • Active malignancy or patient with a history of any malignancy (except non-melanoma skin cancer) with recurrence within 5 years of surgery;
  • Active local or systemic infection or history of local or systemic infection, immune-deficiency, uncontrolled medical conditions, which in the opinion of the Investigator may increase patient risk or confound fusion results;
  • BMI >40% ;
  • History of tobacco smoking within the past 6 months;
  • Has a history of alcoholism, medication or drug abuse, psychosis, is a prisoner, and/or has a personality disorder, poor motivation, emotional or intellectual issues that would likely make the patient unreliable for participation in the study;
  • Are participating in any other clinical trial.

结局指标

主要结局

Fusion grade at 12 month follow-up using CT scans

时间窗: 12 months

Fusion grade at 12 month follow-up using CT scans with a grading system based on: 1. Complete fusion; 2. Partial fusion; 3. No fusion;

次要结局

  • Subject success / Clinical outcome(2-3 weeks, 3 months and 12 months)

研究者

发起方
VG Innovations, LLC
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Clinical Outcome and Fusion Results Using the... | 临床试验